Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + remifentanil versus propofol + remifentanil for anesthesia in surgical abortion of cesarean scar pregnancy
ChiCTR1800018622Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Nov 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, remifentanil and propofol in cesarean scar pregnancy (CSEP) (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoints: Pain score, Vital signs and 1 more. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
dexmedetomidineremifentanilpropofol
03
Conditions
cesarean scar pregnancy (CSEP)
Beyond the preview
Go deeper on ChiCTR1800018622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018622.